Antigen Discovery, Inc.

Antigen Discovery, Inc is an Irvine, California-based proteomic biomarker discovery company specializing in high throughput protein microarray technology.

We provide research services and products to a global clientele, including NIH, pharmaceutical and biotechnology companies, and universities. Our core mission is to simplify proteomic biomarker discovery and enable serological and immune profiling of whole proteomes, significantly reducing the time and cost associated with traditional methods.

ADI’s flexible and robust microarray platform facilitates the discovery of diagnostic biomarkers, vaccine candidates, and therapeutic antibody discovery. Founded in 2004, we pride ourselves on our diverse team of scientists and our commitment to innovation and collaboration, serving the research community worldwide.

Our leadership team brings extensive experience from leading biotechnology and pharmaceutical companies, ensuring a strong foundation for continued growth and success.